ORICOric Pharmaceuticals, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 19725
Ticker: ORIC
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-04-24
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ORIC

Detail

Enriched 2026-08-14 20:47

Market cap: $1,425,224,020
Shares outstanding (class): 103,652,656
Shares outstanding (weighted): 103,652,656
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 111
Location: SOUTH SAN FRANCISCO, CA
Homepage: https://www.oricpharma.com
Description: ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Market cap and share counts drift.

Funds holding this security

107 funds · 112 positions · $258.31M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$34.70M	0.00%	2,738,573 NS	FIGI
ACAP Strategic Fund —	—	$28.20M	0.27%	2,226,067 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$27.51M	0.37%	2,171,512 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$22.05M	0.20%	1,740,383 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$20.55M	0.03%	1,622,032 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$12.48M	0.10%	985,136 NS	FIGI
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST	—	$12.05M	0.76%	951,433 NS	FIGI
T. Rowe Price Integrated U.S. Small-Cap Growth … T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$12.04M	0.15%	950,201 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$10.89M	0.01%	859,828 NS	FIGI
Advantage Advisers Xanthus Fund, L.L.C. —	—	$8.18M	0.28%	645,814 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$5.38M	0.07%	424,422 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$5.11M	0.04%	402,972 NS	FIGI
ROYCE SMALL-CAP TRUST, INC. —	—	$4.84M	0.22%	381,792 NS	FIGI
Meridian Contrarian Fund Meridian Fund Inc	—	$4.69M	0.80%	370,000 NS	FIGI
ROYCE MICRO-CAP TRUST, INC. —	—	$4.34M	0.63%	342,816 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERORIC
FIGI_COMPOSITEBBG00BL5SLH5
FIGI_SHARE_CLASSBBG00BL5SMR2
CIK0001796280
ISINUS68622P1093
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: Oric Pharmaceuticals is a clinical-stage biopharmaceutical company developing cancer therapies, classified under healthcare and pharmaceuticals per its SIC code.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.